Cannabidiol (abbreviated: CBD) is the second most abundant cannabinoid in hemp, after the main active ingredient THC. It therefore belongs to the phytocannabinoids and occurs mainly in the hemp with an amount of up to 2% in the flowers.
Cannabis indica-dominant strains have a higher CBD content than strains dominated by cannabis sativa.
CBD taken alone does not cause any intoxication - it is not essentially psychotropic (with the exception of the slightly sedating effect) - and no relevant (psychic) ​​side effects.

The individual effects of the substance, as well as those of other cannabinoids, have not been fully explored. So there is room for discovery of other medical effects. The effect in isolated form is also to be considered differently than in combination with many other substances of the cannabis plant (for example over 100 cannabinoids alone, as well as flavonoids, terpenes, terpenoids).

CBD mediates its effects via both the CB1 and CB2 receptors. These are receptors of the endocannabinoid system (ECS), are activated or inhibited by the body's own cannabinoids (endocannabinoids) and influence many physiological processes; Among other things, the EC system has an involvement in diseases of the metabolism, disorders of the nervous system and the psyche, pain and inflammatory processes, cancers and diseases of the gastrointestinal tract, to name just a few examples.
CBD can be understood as mediating the effects of THC, as it enhances the analgesic, mind-altering and euphoric properties of THC; On the other hand, it acts as an antagonist by inhibiting the increase in appetite caused by THC, increasing the heart rate as well as any unpleasant psychological effects (increased anxiety, anxiety, paranoia).

For a long time, cannabis breeders were primarily concerned with keeping the CBD content as low as possible in order to achieve a better "high". So it is in many popular cannabis strains at less than one percent. Meanwhile, however, there is a clear trend of medical use in the direction of high-CBD strains, so CBD-rich varieties, which come up with a significant medical potential, without really psychedelic effect.
The effect here is more towards plättend, body-accentuated and pleasantly soothing on the psyche. Therefore, CBD-rich cannabis strains (e.g., in ratio (CBD-THC) 1: 1 or even 2: 1) are ideally suited for treatment of, for example, muscle spasms, sleep disorders, and anxiety.
CBD is not regulated in Germany, Austria and Switzerland and is absolutely legal in its pure form.

Source: